LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) — Healthcare · Share Price, Chart & Market Data
About: LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $28.28 (-2.88%)
LBRXLB Pharmaceuticals Inc Common Stock
Loading watchlist status…
Trade LBRX now
LB Pharmaceuticals Inc Common Stock share price
LBRX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
17 Apr, 7:19 am GMT+0
LBRX price performance
16.187%
5D
6.878%
1M
38.356%
YTD
63.468%
1Y
LBRX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
17 Apr, 7:19 am GMT+0
LBRX details
LBRX Market Signals